世界の注射用スペクチノマイシン塩酸塩市場インサイト・予測（～2027年）

• 英文タイトル：Global Spectinomycin Hydrochloride for Injection Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4041 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は注射用スペクチノマイシン塩酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。注射用スペクチノマイシン塩酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ヒト用、犬用）、用途別市場規模（淋菌による尿路感染症、淋菌による直腸感染症、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・注射用スペクチノマイシン塩酸塩の世界市場概要 ・メーカー別の競争状況、市場シェア ・注射用スペクチノマイシン塩酸塩の種類別市場規模：ヒト用、犬用 ・注射用スペクチノマイシン塩酸塩の用途別市場規模：淋菌による尿路感染症、淋菌による直腸感染症、その他 ・北米の注射用スペクチノマイシン塩酸塩市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの注射用スペクチノマイシン塩酸塩市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの注射用スペクチノマイシン塩酸塩市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の注射用スペクチノマイシン塩酸塩市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの注射用スペクチノマイシン塩酸塩市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Zhejiang Hisun Pharmaceutical Co., Ltd.、Sinopharm Group Guorui Pharmaceutical Co., Ltd.、Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.、Shandong Lukang Pharmaceutical Co., Ltd.、Anhui Wellman Pharmaceutical Co., Ltd.、Jiangsu Muwang Technology Industrial Co., Ltd. ・注射用スペクチノマイシン塩酸塩のバリューチェーン・販売チャネル分析 ・注射用スペクチノマイシン塩酸塩の世界市場動向

Spectinomycin Hydrochloride for Injection is a medication for urinary tract infections caused by Neisseria gonorrhoeae. It is mainly used for infections caused by drug-resistant strains such as penicillin and tetracycline.

Market Analysis and Insights: Global Spectinomycin Hydrochloride for Injection Market
The global Spectinomycin Hydrochloride for Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Spectinomycin Hydrochloride for Injection Scope and Segment
Spectinomycin Hydrochloride for Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Spectinomycin Hydrochloride for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Human Use
Dog Use

Segment by Application
Urinary Tract Infection Caused by Neisseria Gonorrhoeae
Rectal Infection Caused by Neisseria Gonorrhoeae
Others

By Company
Zhejiang Hisun Pharmaceutical Co., Ltd.
Sinopharm Group Guorui Pharmaceutical Co., Ltd.
Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Anhui Wellman Pharmaceutical Co., Ltd.
Jiangsu Muwang Technology Industrial Co., Ltd.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Spectinomycin Hydrochloride for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Spectinomycin Hydrochloride for Injection Market Size Growth Rate by Type
1.2.2 Human Use
1.2.3 Dog Use
1.3 Market by Application
1.3.1 Global Spectinomycin Hydrochloride for Injection Market Size Growth Rate by Application
1.3.2 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
1.3.3 Rectal Infection Caused by Neisseria Gonorrhoeae
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Spectinomycin Hydrochloride for Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Spectinomycin Hydrochloride for Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Spectinomycin Hydrochloride for Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Spectinomycin Hydrochloride for Injection Regions by Sales
2.4.1 Global Top Spectinomycin Hydrochloride for Injection Regions by Sales (2016-2021)
2.4.2 Global Top Spectinomycin Hydrochloride for Injection Regions by Sales (2022-2027)
2.5 Global Top Spectinomycin Hydrochloride for Injection Regions by Revenue
2.5.1 Global Top Spectinomycin Hydrochloride for Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Spectinomycin Hydrochloride for Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Spectinomycin Hydrochloride for Injection Sales by Manufacturers
3.1.1 Global Top Spectinomycin Hydrochloride for Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Spectinomycin Hydrochloride for Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Spectinomycin Hydrochloride for Injection Sales in 2020
3.2 Global Spectinomycin Hydrochloride for Injection Revenue by Manufacturers
3.2.1 Global Top Spectinomycin Hydrochloride for Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Spectinomycin Hydrochloride for Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Spectinomycin Hydrochloride for Injection Revenue in 2020
3.3 Global Spectinomycin Hydrochloride for Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Spectinomycin Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Spectinomycin Hydrochloride for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Spectinomycin Hydrochloride for Injection Sales by Type
4.1.1 Global Spectinomycin Hydrochloride for Injection Historical Sales by Type (2016-2021)
4.1.2 Global Spectinomycin Hydrochloride for Injection Forecasted Sales by Type (2022-2027)
4.1.3 Global Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
4.2 Global Spectinomycin Hydrochloride for Injection Revenue by Type
4.2.1 Global Spectinomycin Hydrochloride for Injection Historical Revenue by Type (2016-2021)
4.2.2 Global Spectinomycin Hydrochloride for Injection Forecasted Revenue by Type (2022-2027)
4.2.3 Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
4.3 Global Spectinomycin Hydrochloride for Injection Price by Type
4.3.1 Global Spectinomycin Hydrochloride for Injection Price by Type (2016-2021)
4.3.2 Global Spectinomycin Hydrochloride for Injection Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Spectinomycin Hydrochloride for Injection Sales by Application
5.1.1 Global Spectinomycin Hydrochloride for Injection Historical Sales by Application (2016-2021)
5.1.2 Global Spectinomycin Hydrochloride for Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
5.2 Global Spectinomycin Hydrochloride for Injection Revenue by Application
5.2.1 Global Spectinomycin Hydrochloride for Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Spectinomycin Hydrochloride for Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
5.3 Global Spectinomycin Hydrochloride for Injection Price by Application
5.3.1 Global Spectinomycin Hydrochloride for Injection Price by Application (2016-2021)
5.3.2 Global Spectinomycin Hydrochloride for Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Spectinomycin Hydrochloride for Injection Market Size by Type
6.1.1 North America Spectinomycin Hydrochloride for Injection Sales by Type (2016-2027)
6.1.2 North America Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2027)
6.2 North America Spectinomycin Hydrochloride for Injection Market Size by Application
6.2.1 North America Spectinomycin Hydrochloride for Injection Sales by Application (2016-2027)
6.2.2 North America Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2027)
6.3 North America Spectinomycin Hydrochloride for Injection Market Size by Country
6.3.1 North America Spectinomycin Hydrochloride for Injection Sales by Country (2016-2027)
6.3.2 North America Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Spectinomycin Hydrochloride for Injection Market Size by Type
7.1.1 Europe Spectinomycin Hydrochloride for Injection Sales by Type (2016-2027)
7.1.2 Europe Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2027)
7.2 Europe Spectinomycin Hydrochloride for Injection Market Size by Application
7.2.1 Europe Spectinomycin Hydrochloride for Injection Sales by Application (2016-2027)
7.2.2 Europe Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2027)
7.3 Europe Spectinomycin Hydrochloride for Injection Market Size by Country
7.3.1 Europe Spectinomycin Hydrochloride for Injection Sales by Country (2016-2027)
7.3.2 Europe Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Spectinomycin Hydrochloride for Injection Market Size by Type
8.1.1 Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Type (2016-2027)
8.1.2 Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2027)
8.2 Asia Pacific Spectinomycin Hydrochloride for Injection Market Size by Application
8.2.1 Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Spectinomycin Hydrochloride for Injection Market Size by Region
8.3.1 Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Spectinomycin Hydrochloride for Injection Market Size by Type
9.1.1 Latin America Spectinomycin Hydrochloride for Injection Sales by Type (2016-2027)
9.1.2 Latin America Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2027)
9.2 Latin America Spectinomycin Hydrochloride for Injection Market Size by Application
9.2.1 Latin America Spectinomycin Hydrochloride for Injection Sales by Application (2016-2027)
9.2.2 Latin America Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2027)
9.3 Latin America Spectinomycin Hydrochloride for Injection Market Size by Country
9.3.1 Latin America Spectinomycin Hydrochloride for Injection Sales by Country (2016-2027)
9.3.2 Latin America Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Spectinomycin Hydrochloride for Injection Market Size by Type
10.1.1 Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Type (2016-2027)
10.1.2 Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2027)
10.2 Middle East and Africa Spectinomycin Hydrochloride for Injection Market Size by Application
10.2.1 Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Spectinomycin Hydrochloride for Injection Market Size by Country
10.3.1 Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
11.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
11.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Overview
11.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product Description
11.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
11.2 Sinopharm Group Guorui Pharmaceutical Co., Ltd.
11.2.1 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Corporation Information
11.2.2 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Overview
11.2.3 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product Description
11.2.5 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Developments
11.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
11.3.1 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Corporation Information
11.3.2 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Overview
11.3.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product Description
11.3.5 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments
11.4 Shandong Lukang Pharmaceutical Co., Ltd.
11.4.1 Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Shandong Lukang Pharmaceutical Co., Ltd. Overview
11.4.3 Shandong Lukang Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Shandong Lukang Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product Description
11.4.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
11.5 Anhui Wellman Pharmaceutical Co., Ltd.
11.5.1 Anhui Wellman Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Anhui Wellman Pharmaceutical Co., Ltd. Overview
11.5.3 Anhui Wellman Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Anhui Wellman Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product Description
11.5.5 Anhui Wellman Pharmaceutical Co., Ltd. Recent Developments
11.6 Jiangsu Muwang Technology Industrial Co., Ltd.
11.6.1 Jiangsu Muwang Technology Industrial Co., Ltd. Corporation Information
11.6.2 Jiangsu Muwang Technology Industrial Co., Ltd. Overview
11.6.3 Jiangsu Muwang Technology Industrial Co., Ltd. Spectinomycin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Jiangsu Muwang Technology Industrial Co., Ltd. Spectinomycin Hydrochloride for Injection Product Description
11.6.5 Jiangsu Muwang Technology Industrial Co., Ltd. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Spectinomycin Hydrochloride for Injection Value Chain Analysis
12.2 Spectinomycin Hydrochloride for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Spectinomycin Hydrochloride for Injection Production Mode & Process
12.4 Spectinomycin Hydrochloride for Injection Sales and Marketing
12.4.1 Spectinomycin Hydrochloride for Injection Sales Channels
12.4.2 Spectinomycin Hydrochloride for Injection Distributors
12.5 Spectinomycin Hydrochloride for Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Spectinomycin Hydrochloride for Injection Industry Trends
13.2 Spectinomycin Hydrochloride for Injection Market Drivers
13.3 Spectinomycin Hydrochloride for Injection Market Challenges
13.4 Spectinomycin Hydrochloride for Injection Market Restraints

14 Key Findings in The Global Spectinomycin Hydrochloride for Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Spectinomycin Hydrochloride for Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Human Use
Table 3. Major Manufacturers of Dog Use
Table 4. Global Spectinomycin Hydrochloride for Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Spectinomycin Hydrochloride for Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Spectinomycin Hydrochloride for Injection Sales by Region (2016-2021) & (K Doses)
Table 7. Global Spectinomycin Hydrochloride for Injection Sales Market Share by Region (2016-2021)
Table 8. Global Spectinomycin Hydrochloride for Injection Sales by Region (2022-2027) & (K Doses)
Table 9. Global Spectinomycin Hydrochloride for Injection Sales Market Share by Region (2022-2027)
Table 10. Global Spectinomycin Hydrochloride for Injection Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Region (2016-2021)
Table 12. Global Spectinomycin Hydrochloride for Injection Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Region (2022-2027)
Table 14. Global Spectinomycin Hydrochloride for Injection Sales by Manufacturers (2016-2021) & (K Doses)
Table 15. Global Spectinomycin Hydrochloride for Injection Sales Share by Manufacturers (2016-2021)
Table 16. Global Spectinomycin Hydrochloride for Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Spectinomycin Hydrochloride for Injection Revenue Share by Manufacturers (2016-2021)
Table 18. Spectinomycin Hydrochloride for Injection Price by Manufacturers 2016-2021 (US$/Dose)
Table 19. Global Spectinomycin Hydrochloride for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Spectinomycin Hydrochloride for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spectinomycin Hydrochloride for Injection as of 2020)
Table 21. Spectinomycin Hydrochloride for Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Spectinomycin Hydrochloride for Injection Product Offered
Table 23. Date of Manufacturers Enter into Spectinomycin Hydrochloride for Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Spectinomycin Hydrochloride for Injection Sales by Type (2016-2021) & (K Doses)
Table 26. Global Spectinomycin Hydrochloride for Injection Sales by Type (2022-2027) & (K Doses)
Table 27. Global Spectinomycin Hydrochloride for Injection Sales Share by Type (2016-2021)
Table 28. Global Spectinomycin Hydrochloride for Injection Sales Share by Type (2022-2027)
Table 29. Global Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Spectinomycin Hydrochloride for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Spectinomycin Hydrochloride for Injection Revenue Share by Type (2016-2021)
Table 32. Global Spectinomycin Hydrochloride for Injection Revenue Share by Type (2022-2027)
Table 33. Spectinomycin Hydrochloride for Injection Price by Type (2016-2021) & (US$/Dose)
Table 34. Global Spectinomycin Hydrochloride for Injection Price Forecast by Type (2022-2027) & (US$/Dose)
Table 35. Global Spectinomycin Hydrochloride for Injection Sales by Application (2016-2021) & (K Doses)
Table 36. Global Spectinomycin Hydrochloride for Injection Sales by Application (2022-2027) & (K Doses)
Table 37. Global Spectinomycin Hydrochloride for Injection Sales Share by Application (2016-2021)
Table 38. Global Spectinomycin Hydrochloride for Injection Sales Share by Application (2022-2027)
Table 39. Global Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Spectinomycin Hydrochloride for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Spectinomycin Hydrochloride for Injection Revenue Share by Application (2016-2021)
Table 42. Global Spectinomycin Hydrochloride for Injection Revenue Share by Application (2022-2027)
Table 43. Spectinomycin Hydrochloride for Injection Price by Application (2016-2021) & (US$/Dose)
Table 44. Global Spectinomycin Hydrochloride for Injection Price Forecast by Application (2022-2027) & (US$/Dose)
Table 45. North America Spectinomycin Hydrochloride for Injection Sales by Type (2016-2021) & (K Doses)
Table 46. North America Spectinomycin Hydrochloride for Injection Sales by Type (2022-2027) & (K Doses)
Table 47. North America Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Spectinomycin Hydrochloride for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Spectinomycin Hydrochloride for Injection Sales by Application (2016-2021) & (K Doses)
Table 50. North America Spectinomycin Hydrochloride for Injection Sales by Application (2022-2027) & (K Doses)
Table 51. North America Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Spectinomycin Hydrochloride for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Spectinomycin Hydrochloride for Injection Sales by Country (2016-2021) & (K Doses)
Table 54. North America Spectinomycin Hydrochloride for Injection Sales by Country (2022-2027) & (K Doses)
Table 55. North America Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Spectinomycin Hydrochloride for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Spectinomycin Hydrochloride for Injection Sales by Type (2016-2021) & (K Doses)
Table 58. Europe Spectinomycin Hydrochloride for Injection Sales by Type (2022-2027) & (K Doses)
Table 59. Europe Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Spectinomycin Hydrochloride for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Spectinomycin Hydrochloride for Injection Sales by Application (2016-2021) & (K Doses)
Table 62. Europe Spectinomycin Hydrochloride for Injection Sales by Application (2022-2027) & (K Doses)
Table 63. Europe Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Spectinomycin Hydrochloride for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Spectinomycin Hydrochloride for Injection Sales by Country (2016-2021) & (K Doses)
Table 66. Europe Spectinomycin Hydrochloride for Injection Sales by Country (2022-2027) & (K Doses)
Table 67. Europe Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Spectinomycin Hydrochloride for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Type (2016-2021) & (K Doses)
Table 70. Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Type (2022-2027) & (K Doses)
Table 71. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Application (2016-2021) & (K Doses)
Table 74. Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Application (2022-2027) & (K Doses)
Table 75. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Region (2016-2021) & (K Doses)
Table 78. Asia Pacific Spectinomycin Hydrochloride for Injection Sales by Region (2022-2027) & (K Doses)
Table 79. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Spectinomycin Hydrochloride for Injection Sales by Type (2016-2021) & (K Doses)
Table 82. Latin America Spectinomycin Hydrochloride for Injection Sales by Type (2022-2027) & (K Doses)
Table 83. Latin America Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Spectinomycin Hydrochloride for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Spectinomycin Hydrochloride for Injection Sales by Application (2016-2021) & (K Doses)
Table 86. Latin America Spectinomycin Hydrochloride for Injection Sales by Application (2022-2027) & (K Doses)
Table 87. Latin America Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Spectinomycin Hydrochloride for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Spectinomycin Hydrochloride for Injection Sales by Country (2016-2021) & (K Doses)
Table 90. Latin America Spectinomycin Hydrochloride for Injection Sales by Country (2022-2027) & (K Doses)
Table 91. Latin America Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Spectinomycin Hydrochloride for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Type (2016-2021) & (K Doses)
Table 94. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Type (2022-2027) & (K Doses)
Table 95. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Application (2016-2021) & (K Doses)
Table 98. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Application (2022-2027) & (K Doses)
Table 99. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Country (2016-2021) & (K Doses)
Table 102. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales by Country (2022-2027) & (K Doses)
Table 103. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 105. Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
Table 106. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Major Businesses
Table 107. Zhejiang Hisun Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 108. Zhejiang Hisun Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product
Table 109. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
Table 110. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Corporation Information
Table 111. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Description and Major Businesses
Table 112. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 113. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product
Table 114. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Developments
Table 115. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Corporation Information
Table 116. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 117. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 118. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product
Table 119. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments
Table 120. Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
Table 121. Shandong Lukang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 122. Shandong Lukang Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 123. Shandong Lukang Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product
Table 124. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
Table 125. Anhui Wellman Pharmaceutical Co., Ltd. Corporation Information
Table 126. Anhui Wellman Pharmaceutical Co., Ltd. Description and Major Businesses
Table 127. Anhui Wellman Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 128. Anhui Wellman Pharmaceutical Co., Ltd. Spectinomycin Hydrochloride for Injection Product
Table 129. Anhui Wellman Pharmaceutical Co., Ltd. Recent Developments
Table 130. Jiangsu Muwang Technology Industrial Co., Ltd. Corporation Information
Table 131. Jiangsu Muwang Technology Industrial Co., Ltd. Description and Major Businesses
Table 132. Jiangsu Muwang Technology Industrial Co., Ltd. Spectinomycin Hydrochloride for Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 133. Jiangsu Muwang Technology Industrial Co., Ltd. Spectinomycin Hydrochloride for Injection Product
Table 134. Jiangsu Muwang Technology Industrial Co., Ltd. Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Spectinomycin Hydrochloride for Injection Distributors List
Table 138. Spectinomycin Hydrochloride for Injection Customers List
Table 139. Spectinomycin Hydrochloride for Injection Market Trends
Table 140. Spectinomycin Hydrochloride for Injection Market Drivers
Table 141. Spectinomycin Hydrochloride for Injection Market Challenges
Table 142. Spectinomycin Hydrochloride for Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Spectinomycin Hydrochloride for Injection Product Picture
Figure 2. Global Spectinomycin Hydrochloride for Injection Market Share by Type in 2020 & 2027
Figure 3. Human Use Product Picture
Figure 4. Dog Use Product Picture
Figure 5. Global Spectinomycin Hydrochloride for Injection Market Share by Application in 2020 & 2027
Figure 6. Urinary Tract Infection Caused by Neisseria Gonorrhoeae
Figure 7. Rectal Infection Caused by Neisseria Gonorrhoeae
Figure 8. Others
Figure 9. Spectinomycin Hydrochloride for Injection Report Years Considered
Figure 10. Global Spectinomycin Hydrochloride for Injection Sales 2016-2027 (K Doses)
Figure 11. Global Spectinomycin Hydrochloride for Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Spectinomycin Hydrochloride for Injection Revenue 2016-2027 (US$ Million)
Figure 13. Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Spectinomycin Hydrochloride for Injection Sales Market Share by Region (2016-2021)
Figure 15. Global Spectinomycin Hydrochloride for Injection Sales Market Share by Region (2022-2027)
Figure 16. North America Spectinomycin Hydrochloride for Injection Sales YoY (2016-2027) & (K Doses)
Figure 17. North America Spectinomycin Hydrochloride for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Spectinomycin Hydrochloride for Injection Sales YoY (2016-2027) & (K Doses)
Figure 19. Europe Spectinomycin Hydrochloride for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Spectinomycin Hydrochloride for Injection Sales YoY (2016-2027) & (K Doses)
Figure 21. Asia-Pacific Spectinomycin Hydrochloride for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Spectinomycin Hydrochloride for Injection Sales YoY (2016-2027) & (K Doses)
Figure 23. Latin America Spectinomycin Hydrochloride for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Spectinomycin Hydrochloride for Injection Sales YoY (2016-2027) & (K Doses)
Figure 25. Middle East & Africa Spectinomycin Hydrochloride for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Spectinomycin Hydrochloride for Injection Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Spectinomycin Hydrochloride for Injection Revenue in 2020
Figure 28. Spectinomycin Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
Figure 30. Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
Figure 31. Global Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
Figure 32. Global Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
Figure 33. North America Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
Figure 34. North America Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
Figure 35. North America Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
Figure 36. North America Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
Figure 37. North America Spectinomycin Hydrochloride for Injection Sales Share by Country (2016-2027)
Figure 38. North America Spectinomycin Hydrochloride for Injection Revenue Share by Country (2016-2027)
Figure 39. United States Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
Figure 42. Europe Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
Figure 43. Europe Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
Figure 44. Europe Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
Figure 45. Europe Spectinomycin Hydrochloride for Injection Sales Share by Country (2016-2027)
Figure 46. Europe Spectinomycin Hydrochloride for Injection Revenue Share by Country (2016-2027)
Figure 47. Germany Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 48. France Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Spectinomycin Hydrochloride for Injection Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Spectinomycin Hydrochloride for Injection Revenue Share by Region (2016-2027)
Figure 58. China Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 61. India Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
Figure 68. Latin America Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
Figure 70. Latin America Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Spectinomycin Hydrochloride for Injection Sales Share by Country (2016-2027)
Figure 72. Latin America Spectinomycin Hydrochloride for Injection Revenue Share by Country (2016-2027)
Figure 73. Mexico Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Spectinomycin Hydrochloride for Injection Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Spectinomycin Hydrochloride for Injection Revenue Share by Country (2016-2027)
Figure 83. Turkey Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Spectinomycin Hydrochloride for Injection Revenue (2016-2027) & (US$ Million)
Figure 86. Spectinomycin Hydrochloride for Injection Value Chain
Figure 87. Spectinomycin Hydrochloride for Injection Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---